Steroid News and Research

RSS

Researchers identify gene expression and biological pathways for healing gingivitis

Gingivitis, which may affect more than one-half of the U.S. adult population, is a condition commonly attributed to lapses in simple oral hygiene habits. However, a new study shows that development and reversal of gingivitis at the molecular level is apparently much more complicated than its causes might indicate.

8 Dec 2009

Cysteine-rich whey protein supplement may maintain or increase weight in advanced NSCLC patients

Immunotec Inc. announced today the enrollment of the first patient in the US Cancer trial of IMN 1207 being run at Beaumont Hospital's Community Clinical Oncology Program (CCOP) in Royal Oak, Michigan. The goal of the study is to determine the effect of IMN 1207, a cysteine-rich whey protein supplement, in preventing additional weight loss in patients with stage IV (advanced) non-small cell lung cancer.

7 Dec 2009

Vitamin D supplements may aid in treating cancer

The findings support the growing association between vitamin D and cancer risk and outcomes, and suggest that vitamin D supplements might help even those patients already diagnosed with some forms of cancer, says Dr. Drake.

7 Dec 2009

NPA responds to DEA's steroid classification action

"The Natural Products Association and its members are very excited to see the DEA use the additional power the NPA and many others worked so hard to give to it through the Anabolic Steroid Control Act of 2004.

5 Dec 2009

Patients new to chronic disease medication face risk of medication discontinuation, finds study

In a new study published online today by Clinical Therapeutics, researchers from Adheris, Inc., an inVentiv Health company, found that patients new to chronic disease medication face the greatest risk of medication discontinuation during the first 30 days of treatment—with rates of discontinuation ranging from 29.6% to 78.1%.

5 Dec 2009

BUSM researchers report an inverse association between dairy intake and fibroid risk

Boston University School of Medicine (BUSM) researchers at the Slone Epidemiology Center found that black women with high intake of dairy products have a reduced incidence of uterine leiomyomata (fibroids). This report, based on the Black Women's Health Study, appears in the current issue of the American Journal of Epidemiology.

4 Dec 2009

Researchers discover mechanism that explains how chromosomal translocations are not random

Researchers at the UC San Diego School of Medicine have pinpointed a mechanism that may help explain how chromosomal translocations - the supposedly random shuffling of large chunks of DNA that frequently lead to cancer - aren't so random after all. They have developed a model of such chromosomal mix-ups in prostate cancer which indicates that the male sex hormone (androgen) receptor unexpectedly plays a key role in driving specific translocations in the development of cancer.

4 Dec 2009

Lung disease linked to the use of contaminated well water in a CPAP machine

Many people rely on continuous positive airway pressure (CPAP) machines as a safe and effective treatment for sleep apnea. But a new case report describes a rare complication—a lingering inflammatory disease of the lungs, apparently related to the use of contaminated well water in a CPAP machine. The report appears in the December Southern Medical Journal, official journal of the Southern Medical Association.

3 Dec 2009

Positive results from DermaGen's Phase I/IIa AMP study of atopic dermatitis

DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.

2 Dec 2009

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Novartis announced today that new data, including a late-breaking presentation on Tasigna® (nilotinib) 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's hematology portfolio in advancing the care of patients.

2 Dec 2009

Rebecca Gomez develops anuleaf AD to relieve hemorrhoid sufferers of their symptoms

Many drug companies desperately do not want revealed to the public that over-the-counter hemorrhoid treatments may worsen problems and cause skin damage.

1 Dec 2009

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

Ipsen today announced the initiation of an international, multi-center, controlled, randomized Phase II clinical trial to evaluate the safety and efficacy of BN83495, its investigational first-in-class steroid sulfatase (STS) inhibitor, in advanced endometrial cancer.

25 Nov 2009

New findings suggest current system of classifying psychoactive drugs in UK may need to be revisited

Drug users are well informed about the harms associated with the drugs they use, and perceive alcohol and tobacco to be amongst the most dangerous substances, according to a survey by UCL (University College London) and Imperial College London researchers.

25 Nov 2009

Inadequate asthma control is present in 26% to 45% of children, says review

Asthma is the commonest chronic disease in children and a major reason for admissions to hospital, yet inadequate asthma control is present in 26% to 45% of children, states a review http://www.cmaj.ca/embargo/cmaj071638.pdf in CMAJ (Canadian Medical Association Journal) www.cmaj.ca.

23 Nov 2009

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

OncoVista Innovative Therapies, Inc., reported that the AdnaTest BreastCancer Select & Detect kit, manufactured by AdnaGen AG (Langenhagen, Germany), is now available for research as well as for pay-out-of-pocket patients in the Czech Republic and Slovakia.

23 Nov 2009

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

23 Nov 2009

Global initiative battles online supply of dangerous and illegal medicines

In response to an ever-increasing number of websites supplying dangerous and illegal medicines, Operation Pangea II, involving 24 countries, was coordinated by INTERPOL and the World Health Organization's International Medical Products Anti-Counterfeiting Taskforce (IMPACT) to highlight the dangers of buying medicines online.

20 Nov 2009

Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects

Researchers from the German Sport University Cologne in Germany found that non-steroidal and tissue-selective anabolic agents such as Selective Androgen Receptor Modulators (SARMs) are being sold on the black market for their performance enhancing qualities.

19 Nov 2009

Third patent application for COPD stem cell therapy filed by Entest BioMedical

Entest BioMedical Inc. (OTC Bulletin Board: ENTB) announced today the filing of a third patent application relating to the area of chronic obstructive pulmonary disease (COPD), a condition that affects more than 5 million patients in the United States, resulting in more than 120,000 deaths per year. The application covers an implantable medical device useful in re-directing the immune system to stop tissue inflammation.

18 Nov 2009

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

17 Nov 2009

Steroid News and Research

Researchers identify gene expression and biological pathways for healing gingivitis

Cysteine-rich whey protein supplement may maintain or increase weight in advanced NSCLC patients

Vitamin D supplements may aid in treating cancer

NPA responds to DEA's steroid classification action

Patients new to chronic disease medication face risk of medication discontinuation, finds study

BUSM researchers report an inverse association between dairy intake and fibroid risk

Researchers discover mechanism that explains how chromosomal translocations are not random

Lung disease linked to the use of contaminated well water in a CPAP machine

Positive results from DermaGen's Phase I/IIa AMP study of atopic dermatitis

New data demonstrating the strength of Novartis' hematology portfolio to be presented

Rebecca Gomez develops anuleaf AD to relieve hemorrhoid sufferers of their symptoms

Initiation of Phase II clinical trial to evaluate the efficacy of BN83495 announced

New findings suggest current system of classifying psychoactive drugs in UK may need to be revisited

Inadequate asthma control is present in 26% to 45% of children, says review

AdnaTest BreastCancer Select & Detect kit now available in the Czech Republic and Slovakia

New target may promote development of novel therapies for chronic sinusitis

Global initiative battles online supply of dangerous and illegal medicines

Findings suggest athletes abuse non-approved therapeutic compounds for performance enhancing effects

Third patent application for COPD stem cell therapy filed by Entest BioMedical

Phase II clinical study to evaluate Nanocort commenced

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News